Ondansetron HCL (Zofran TM, Glaxo).
Frankiewicz
V
V
Farrington
E
E
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy* / Q000451:nursing; D009369:Neoplasms / Q000188:drug therapy*; D017294:Ondansetron; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy* / Q000451:nursing
D000970:Antineoplastic Agents; D007093:Imidazoles; D017294:Ondansetron